Physician profile
James Mu
NPI 1700875572
$3,506.76
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $664 · 2021: $957 · 2022: $699 · 2023: $302 · 2024: $13.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $563.60 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $541.56 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $426.93 | 2019-2023 | Wegovy |
| Abbvie INC. | $315.33 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $312.78 | 2021-2023 | Xifaxan |
| Allergan, INC. | $244.97 | 2019 | |
| Janssen Pharmaceuticals, INC | $162.43 | 2019-2023 | Spravato |
| Pfizer INC. | $156.18 | 2019-2024 | |
| Glaxosmithkline, LLC. | $126.58 | 2021-2022 | |
| Lilly USA, LLC | $118.90 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $112.86 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.49 | 2019-2021 | |
| Esperion Therapeutics, INC. | $50.49 | 2023 | Nexletol |
| Sanofi Pasteur INC. | $48.21 | 2019-2021 | |
| Amgen INC. | $48.19 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $39.50 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $39.35 | 2022 | |
| Daiichi Sankyo INC. | $26.49 | 2023 | Injectafer |
| Amarin Pharma, INC. | $23.81 | 2020 | |
| Vanda Pharmaceuticals INC. | $23.27 | 2021 | |
| Biocryst US Sales Co., LLC | $19.17 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.82 | 2023 | |
| Hologic Sales and Service, LLC | $16.55 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.